Study guide

4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring

Certified Burn Registered Nurse CBRN

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Foundations of Burn Care

1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones

2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response

2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology

3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria

3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics

4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)

4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy

5 Chapter 5: Airway Management & Inhalation Injury Management

5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)

6 Chapter 6: Acute Multisystem Assessment & Critical Care Management

6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection

7 Chapter 7: Hypermetabolism & Nutritional Support

7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation

8 Chapter 8: Pain Management in Burn Care

8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction

9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus

9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients

10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings

10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances

11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure

11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy

12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion

13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries

13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

14 Chapter 14: Special Burn Populations & Cutaneous Syndromes

14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries

15 Chapter 15: Rehabilitation, Scar Management & Reconstruction

15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management

16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage

16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response

4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring

Key Takeaways Explain This Topic AI

Hourly urine output (UOP) measured via an indwelling Foley catheter with a temperature-sensing urometer is the primary gold-standard clinical endpoint for titrating burn fluid resuscitation.

Target UOP parameters are 0.5 mL/kg/hr (30–50 mL/hr) for adults, 0.5–1.0 mL/kg/hr for children (<30 kg) (1.0–1.5 mL/kg/hr in infants), and 75–100 mL/hr (1.5–2.0 mL/kg/hr) for high-voltage electrical injuries with pigmenturia.

Resuscitation formulas provide only an initial starting rate; the nurse must actively titrate IV crystalloid infusions up or down by 10% to 20% hourly based on UOP trends.

Large, rapid crystalloid boluses and abrupt IV rate stoppages must be avoided because they worsen interstitial edema and cause hemodynamic instability.

Secondary resuscitation endpoints include base deficit normalization (-2 to +2 mEq/L), serum lactate clearance (<2.0 mmol/L), MAP ≥65 mmHg, heart rate <120 bpm, and advanced volumetric indicators (GEDI, EVLWI, PPV/SVV).

Last updated: August 2026

4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring

Core Knowledge: Resuscitation formulas (such as Parkland or ABA Consensus) provide only a mathematical estimation of initial fluid requirements. The defining competency of the Certified Burn Registered Nurse (CBRN) is the active, hourly titration of intravenous fluids to objective physiological endpoints. The primary clinical endpoint of burn resuscitation is hourly urine output (UOP) , which directly reflects end-organ renal perfusion. Relying solely on blood pressure or heart rate leads to significant over- or under-resuscitation.

1. Urine Output: The Primary Clinical Endpoint

In acute burn shock, systemic vasoconstriction, microvascular leakage, and catecholamine surges obscure peripheral perfusion markers. The kidneys receive approximately 20% to 25% of cardiac output; consequently, renal glomerular filtration and hourly urine production serve as the most sensitive, real-time indicators of adequate intravascular volume and visceral perfusion. HOURLY URINE OUTPUT (UOP) RESUSCITATION TARGETS

  • ┌────────────────────────────────────────┬────────────────────────────────────────┐
  • │ PATIENT POPULATION │ TARGET HOURLY URINE OUTPUT │
  • ├────────────────────────────────────────┼────────────────────────────────────────┤
  • │ Adults & Adolescents (≥14 yr / ≥30 kg) │ 0.5 mL/kg/hr (or 30 to 50 mL/hr) │
  • │ Children (<14 yr / <30 kg) │ 0.5 to 1.0 mL/kg/hr │
  • │ Infants (<1 year) │ 1.0 to 1.5 mL/kg/hr │
  • │ High-Voltage Electrical / Pigmenturia │ 75 to 100 mL/hr (Adults: 1.5-2.0 mL/kg)│
  • └────────────────────────────────────────┴────────────────────────────────────────┘
  • Monitoring Requirements

Indwelling Urinary Catheter with Inline Urometer: Mandatory for all patients receiving formal fluid resuscitation (≥20% TBSA adults, ≥10–15% TBSA pediatrics). A standard drainage bag is insufficient; an hourly closed-system urometer with burette chamber is required for exact hourly volume measurement.

Temperature-Sensing Foley: Preferred in major burns to monitor continuous core body temperature and detect hypothermia (<35°C) or malignant hyperthermia.

2. Fluid Titration Protocol: The 10% to 20% Hourly Adjustment Rule

Fluid titration is a dynamic process. Resuscitation fluids should never remain at a static calculated rate if urine output deviates from target ranges. HOURLY FLUID TITRATION ALGORITHM

  • │
  • [Check Hourly UOP]
  • │
  • ┌───────────────────────────────┼───────────────────────────────┐
  • ▼ ▼ ▼
  • [LOW UOP] [TARGET UOP] [HIGH UOP]
  • <0.5 mL/kg/hr 0.5 - 1.0 mL/kg/hr >1.0 mL/kg/hr
  • (<30 mL/hr adult) (30 - 50 mL/hr adult) (>50 mL/hr adult)
  • │ │ │
  • ▼ ▼ ▼
  • INCREASE IV Rate by MAINTAIN Current Rate DECREASE IV Rate by
  • 10% to 20% Continue Hourly 10% to 20%
  • (e.g., +50-100 mL/hr) Monitoring (e.g., -50-100 mL/hr)
  • Critical Titration Principles

Avoid Crystalloid Boluses: Unless the patient is in profound, unmeasurable hypovolemic cardiovascular collapse, avoid manual 500 mL or 1,000 mL fluid boluses . Rapid crystalloid boluses spike hydrostatic pressure, accelerate capillary extravasation into damaged tissues, worsen edema, and trigger rebound oliguria once the bolus transiently redistributes.

Incremental Adjustments (10–20%): Increase or decrease the continuous hourly infusion rate by 10% to 20% (typically 50 to 150 mL/hr in adults). Re-evaluate urine output at the next 1-hour interval.

Do Not Abruptly Halt Fluids: Never stop resuscitation fluids completely in response to high urine output. Abrupt cessation leads to rapid intravascular collapse due to continuous ongoing capillary leak. Down-titrate steadily by 10% to 20% each hour.

Accounting for Physiological Lag Time: The kidneys exhibit a 30- to 60-minute physiological lag time in response to fluid rate changes. Avoid making erratic, drastic changes every 15 minutes.

3. Secondary Physiological Endpoints & Advanced Monitoring

While urine output is the primary guide, multi-parameter assessment ensures comprehensive tissue perfusion and prevents occult cellular dysoxia.

Physiological Parameter Resuscitation Target Clinical Significance & Limitations in Burns

Base Deficit / Excess -2 to +2 mEq/L ; (Normalizing trend) Reflects systemic tissue hypoperfusion and anaerobic metabolism. A worsening base deficit (e.g., -6 to -10 mEq/L) signals inadequate resuscitation even if UOP appears adequate.

Serum Lactate < 2.0 mmol/L ; (Lactate clearance >20%/2h) Marker of anaerobic glycolysis and cellular hypoxia. Persistent lactic acidosis indicates ongoing tissue ischemia or uncorrected shock.

Mean Arterial Pressure (MAP) ≥ 65 mmHg Ensures adequate coronary and cerebral perfusion pressure. Limitation: Intense catecholamine vasoconstriction may maintain normal BP despite severe intravascular hypovolemia.

Heart Rate < 120 bpm (Adults) Sinus tachycardia is common due to hypercatecholaminemia; progressive worsening (>130 bpm) indicates hypovolemia, pain, or under-resuscitation.

Central Venous Pressure (CVP) 6 to 10 mmHg Poor surrogate for volume responsiveness in burns due to chest wall compliance changes, mechanical ventilation, and positive end-expiratory pressure (PEEP).

Mixed Venous Oxygen ( S c v O 2 ScvO_2 S c v O 2 ​ / S v O 2 SvO_2 S v O 2 ​ ) ≥ 65% to 70% Measures balance between oxygen delivery ( D O 2 DO_2 D O 2 ​ ) and systemic oxygen consumption ( V O 2 VO_2 V O 2 ​ ). Low S c v O 2 ScvO_2 S c v O 2 ​ (<65%) indicates inadequate cardiac output.

Advanced Functional Hemodynamics (Pulse Contour & Thermodilution)

In complex resuscitations (e.g., elderly patients, severe inhalation injury, multi-organ trauma, or patients failing standard titration), advanced hemodynamic monitoring is employed:

Transpulmonary Thermodilution (PiCCO / EV1000):

Global End-Diastolic Volume Index (GEDI): Target 680 to 800 mL/m² (measures true preload volume independent of intrathoracic pressure artifacts).

Extravascular Lung Water Index (EVLWI): Target < 10 mL/kg . An elevating EVLWI (>12–14 mL/kg) provides early warning of impending pulmonary edema and fluid creep before clinical hypoxia develops.

Dynamic Parameters (PPV & SVV):

Pulse Pressure Variation (PPV) / Stroke Volume Variation (SVV): In mechanically ventilated patients in normal sinus rhythm without spontaneous breathing efforts, a PPV/SVV > 12% to 13% indicates fluid responsiveness (patient will benefit from volume expansion).

4. Titration Decision Matrix & Scenario Walkthroughs

The following clinical matrix guides nursing decision-making when reconciling multiple conflicting hemodynamic variables: RESUSCITATION DECISION MATRIX

┌───────────────┬──────────────┬───────────────┬───────────────────────────────┬───────────────────────────────┐

│ Hourly UOP │ MAP (mmHg) │ Base Deficit │ Clinical Assessment │ Recommended Nursing Action │

├───────────────┼──────────────┼───────────────┼───────────────────────────────┼───────────────────────────────┤

  • │ Low (<0.5) │ Low (<65) │ Worsening (-8)│ Under-resuscitated / Shock │ Increase IV rate by 20%; │
  • │ │ │ │ │ re-check UOP in 1 hour │

├───────────────┼──────────────┼───────────────┼───────────────────────────────┼───────────────────────────────┤

  • │ Low (<0.5) │ Normal (75) │ Normal (-1) │ Catheter occlusion vs. │ Flush/irrigate Foley; check │
  • │ │ │ │ localized renal constriction │ for kinks; if clear, +10-15% │

├───────────────┼──────────────┼───────────────┼───────────────────────────────┼───────────────────────────────┤

│ Normal (0.6) │ Normal (72) │ Normal (-2) │ Euvolemic / Target Reached │ Maintain current infusion rate│

├───────────────┼──────────────┼───────────────┼───────────────────────────────┼───────────────────────────────┤

│ High (>1.2) │ Normal (80) │ Normal (0) │ Over-resuscitating / Creep │ Decrease IV rate by 10-20% │

├───────────────┼──────────────┼───────────────┼───────────────────────────────┼───────────────────────────────┤

  • │ High (>1.5) │ Low (<60) │ Worsening (-6)│ Osmotic Diuresis (Glycosuria) │ Check urine glucose & serum Na│
  • │ │ │ │ or Alcohol/Diuretic effect │ Do NOT decrease fluids! │

└───────────────┴──────────────┴───────────────┴───────────────────────────────┴───────────────────────────────┘

5. Confounding Factors in Resuscitation Assessment

Several clinical conditions distort urine output and vital sign interpretation during burn resuscitation:

Stress-Induced Glycosuria & Osmotic Diuresis: Massive release of cortisol and epinephrine induces severe stress hyperglycemia. When blood glucose exceeds the renal threshold (~180 mg/dL), unabsorbed tubular glucose acts as an osmotic diuretic. The patient produces copious "false-positive" urine output (>1.5 mL/kg/hr) despite worsening intravascular dehydration and profound cellular hypoperfusion. Nursing Action: Test urine for glucose and ketones; initiate intravenous insulin infusion; titrate IV fluids to base deficit and lactate rather than osmotic urine output.

High-Voltage Electrical Injury & Pigmenturia: Damaged skeletal muscle releases myoglobin, and hemolyzed erythrocytes release hemoglobin. In acidic urine, myoglobin precipitates into Tamm-Horsfall protein complexes, causing mechanical tubular obstruction and direct tubular cytotoxicity. Target UOP: Must be maintained at 75 to 100 mL/hr in adults (or 1.5–2.0 mL/kg/hr) until urine is visibly crystal clear.

Pre-existing Renal Disease or Acute Tubular Necrosis (ATN): Patients with acute ischemic tubular injury lose the ability to concentrate urine or produce filtrate. In oliguric renal failure refractory to fluid challenges, continuing to escalate crystalloids causes catastrophic fluid creep. Early continuous renal replacement therapy (CRRT) is indicated.

Chronic Beta-Blocker Therapy: Blunts compensatory tachycardia, masking early signs of hypovolemia.